OR WAIT 15 SECS
Agilent Technologies and Chungnam National University have agreed to develop new applications, methods, technologies and software tools in the field of glycomics ? the study of complex sugars.
Agilent Technologies and Chungnam National University have agreed to develop new applications, methods, technologies and software tools in the field of glycomics — the study of complex sugars. As a result of the agreement, the university aims to identify and develop biomarkers for diseases such as cancer, leading to the development of therapeutic antibody products. It is Agilent’s first partnership of this kind with a university in Asia.
“Chungnam National University, with our motto, ‘Creativity, development and service to the community’ has been offering the best possible environment for excellence in research and education for over 50 years,” said professor Kwang Hwa Chung, dean, Chungnam National University. “We are proud to announce this collaboration with Agilent that will see our university using the latest analytical and scientific technologies for research in glycomics.”
The research will be jointly led by Professor Hyun Joo An, department of analytical science and technology at Chungnam National University’s Graduate School of Analytical Science and Technology (GRAST) and head of the new Asia Glycomics Education Centre and by Rudolf Grimm, Agilent’s director of science and technology and manager of collaborations in the Asia Pacific region.